In the dynamic landscape of Philippine commerce, the lines between partnership, investment, and competition often blur. A common yet legally precarious scenario arises when an investor in one corporation publicly endorses or promotes a direct competitor. While "business is business," the Philippine legal framework—primarily governed by the Revised Corporation Code (RCC) and the Philippine Competition Act—imposes strict boundaries on such behavior to protect corporate integrity and shareholder value.
1. The Fiduciary Foundation: Loyalty and Care
The cornerstone of Philippine corporate law is the fiduciary relationship between those who control a corporation and the corporation itself. Under Section 30 of the RCC, directors and trustees are mandated to perform their duties with "the devotion of a faithful agent."
When an investor also holds a seat on the Board of Directors or serves as an officer, their endorsement of a competitor is not merely a personal choice; it is a potential breach of the Duty of Loyalty.
Key Provisions under the Revised Corporation Code (RCC):
- Section 31 (Liability of Directors/Officers): Directors or officers who acquire any personal or pecuniary interest in conflict with their duty shall be liable jointly and severally for all damages resulting therefrom.
- Section 33 (Disloyalty of a Director): This is the "Doctrine of Corporate Opportunity." If a director, by virtue of their office, acquires for themselves a business opportunity which should belong to the corporation, they must account for all profits by refunding the same to the corporation, unless the act is ratified by a two-thirds (2/3) vote of the stockholders.
2. Passive Investor vs. Controlling Investor
The legal implications of endorsing a competitor vary significantly based on the investor's level of influence:
The Passive Shareholder
Generally, a minority shareholder who has no management role and no access to trade secrets is not bound by fiduciary duties to the corporation. They are free to invest in and endorse competing brands, provided they do not violate specific Shareholders’ Agreements (SHA) or non-compete clauses.
The Controlling Shareholder or Director
If the investor has "control" or sits on the board, the endorsement becomes a legal liability. An endorsement is a form of social and commercial capital. By directing that capital toward a competitor, the investor may be:
- Devaluing the original investment: Actively harming the market share of the company they are supposed to protect.
- Using Proprietary Information: Using insights gained from Company A to highlight why Company B is "better," which can border on a violation of trade secret protections.
3. The Doctrine of Corporate Opportunity
In the Philippine context, if an investor-director endorses a competitor, the courts look at whether they are diverting a "corporate opportunity." If a director discovers a lucrative path (e.g., a new market or a marketing strategy) and, instead of presenting it to their own board, endorses a competitor to take that path, they have violated Section 33 of the RCC.
Note: Even if the director used their own funds or personal social media platform for the endorsement, the conflict remains if the act results in the "disloyalty" to the corporation's interests.
4. Interlocking Directorates and Competition Law
The Philippine Competition Commission (PCC) monitors Interlocking Directorates under the Philippine Competition Act (RA 10667). If an investor holds board seats in two competing firms, an endorsement of one over the other isn't just a corporate governance issue—it could be seen as an Anti-Competitive Agreement.
- Market Manipulation: If the endorsement is part of a broader scheme to divide the market or fix prices between the two companies, the investor could face administrative and even criminal penalties.
- Conflict of Interest Policies: Most Philippine publicly listed companies (PLCs) are required by the SEC’s Code of Corporate Governance to have strict Conflict of Interest (COI) policies that mandate immediate disclosure of any interest in a competitor.
5. Remedies and Consequences
If a corporation determines that an investor (with fiduciary duties) has caused harm through the endorsement of a competitor, the following actions may be taken:
| Remedy | Description |
|---|---|
| Derivative Suit | Minority stockholders may sue on behalf of the corporation to recover damages from the disloyal director/investor. |
| Account of Profits | Under Section 33, the investor may be forced to turn over any gains made from the competing business to the original corporation. |
| Removal | Stockholders representing a majority of the outstanding capital stock may remove the director for cause (breach of trust). |
| Injunction | The corporation may seek a court order to stop the investor from further endorsing or participating in the competitor's activities. |
6. Practical Safeguards for Philippine Businesses
To prevent these conflicts, Philippine corporations typically utilize:
- Non-Compete and Non-Solicitation Clauses: Explicitly barring investors (especially VCs and PE firms) from endorsing or investing in "direct competitors" for a specific duration.
- Mandatory Disclosure: Requiring investors to declare all existing portfolios to check for "conflicts of interest" before the subscription of shares.
- Ethical Walls: In firms that invest in broad sectors, creating internal barriers to ensure that sensitive data from one company does not bleed into the marketing strategy of a competitor.
Summary
In the Philippines, an endorsement is rarely "just a post" or "just a quote." For those in positions of corporate trust, it is a legal act that must be weighed against the duty of undivided loyalty. While the law allows for a free market, it does not allow a director to hold the steering wheel of one ship while cheering for the pirate vessel alongside it.